Studsvik Distributes Listing Particulars for IPO

Studsvik Distributes Listing Particulars for IPO Studsvik's initial public offering (IPO) on OM Stockholm Exchange is planned for May 4, 2001, providing that Atle's General Meeting of Shareholders decides to distribute Studsvik's shares on April 19, 2001. Studsvik is a high-tech company with a leading position in nuclear technology. The Group has 1,200 employees and, in 2001, reported net sales of just over SEK 800 million. Studsvik has customers all over the world. Customers mainly comprise nuclear power plants and nuclear fuel vendors as well as pharmaceutical companies and companies in the health care sector. On condition that Atle's General Meeting of Shareholders decides, on April 19, 2001, to distribute Studsvik's shares to Atle's existing shareholders, Studsvik will initially be owned by over 10,000 shareholders. Atle's shareholders will receive one share in Studsvik for every ten shares in Atle. The proposed record date is April 24, 2001, which means that the final date for trading in Atle shares, including the right to receive Studsvik shares, is April 19. A Listing Particulars will be distributed to Atle's shareholders from April 4. A PDF version of the Listing Particulars will be available at http://www.studsvik.se/ from April 4. Nyköping, April 4, 2001 Studsvik AB (publ) For further information, contact: Carsten Olsson, Chief Executive Officer, Studsvik Group, tel: +46 155 22 10 20, cellphone: +46 709 67 70 20 Thomas Backteman, Senior Vice President, Communications and Investor Relations, Studsvik AB, tel: +46 155 22 10 66, cellphone: +46 709 67 70 66. Facts about Studsvik Studsvik is a high-tech company, focusing on the nuclear power industry and nuclear medicine. Business is conducted through four Strategic Business Units (SBUs): Nuclear Technology, Waste & Decommissioning, Industrial Services and Nuclear Medicine Nuclear Technology offers products and services related to nuclear power plant operation. These include the testing and analysis of nuclear fuel and materials, computer codes for reactor operation, consulting and instrumentation for the measurement of radiation. Activities are dependent on Studsvik's nuclear reactors and specialist laboratories, located outside Nyköping. Waste & Decommissioning Waste & Decommissioning treats low and intermediate level waste from nuclear reactors and provides services for the dismantling of nuclear facilities. European operations focus on the treatment of low level waste in Studsvik's incineration and melting facilities located outside Nyköping. US operations, conducted at Studsvik's facilities in Erwin, Tennessee, include volume and weight reduction of ion-exchange resins from commercial nuclear power plants in the USA.e Industrial Services Industrial Services mainly provides services to the nuclear power industry and also offers services to other industries. Operations include decontamination, health physics, chemical cleaning and dismantling of nuclear facilities as well as process cleaning Activities have historically been concentrated to Sweden. However, since the German company, SINA, was acquired in 1998, the German business accounts for more than a half of the SBU's income. Nuclear Medicine Nuclear Medicine provides a number of nuclear-related products and methods for medical use. The range includes a method for the treatment of brain tumors, dosimetry services for hospitals, dentists and veterineries and a number of radioisotopes. Prospect ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/04/04/20010404BIT00640/bit0002.doc http://www.bit.se/bitonline/2001/04/04/20010404BIT00640/bit0002.pdf